Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Master Style Public Company Limited (MASTER.BK)
Bangkok, TH
Master Style Public Company Limited operates a comprehensive cosmetic surgery facility in Thailand, known as Masterpiece Hospital. This institution offers a broad spectrum of aesthetic procedures, including nasal reshaping (rhinoplasty), eyebrow lifts, facial contouring, breast enhancement or reduction surgeries, body sculpting through liposuction, eye operations, and facial reconstruction. Furthermore, its services extend to hair transplantation and other hair restoration treatments, as well as advanced skincare and laser therapies. The company was founded in 2012 and maintains its primary base of operations in Dusit, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.61% | +1.86% | -3.53% | -27.43% | -11.83% | +10.07% | -37.88% | -86.99% | -77.59% | -77.59% | -77.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-11.7% Q1'26: -8.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-61.9% Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+14.0% Q1'26: +2.8% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.8% ★ Q1'26: +12.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+4.9% Q1'26: +4.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.12× Q1'26: 1.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 3 EPS Ana. |
Dec 2027 2 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
1.48B
est: 1.38B (+7.5%)
|
1.92B
est: 2.03B (-5.8%)
|
2.14B
est: 2.14B (-0.2%)
|
1.88B
est: 1.91B (-1.1%)
|
1.92B
1.90B – 1.94B
+0.7% YoY
|
2.00B
1.99B – 2.00B
+4.1% YoY
|
2.13B
2.11B – 2.14B
+6.6% YoY
|
| EBITDA |
421.58M
est: 449.74M (-6.3%)
|
574.55M
est: 626.12M (-8.2%)
|
783.47M
est: 658.76M (+18.9%)
|
416.70M
est: 586.60M (-29.0%)
|
590.66M
584.38M – 596.93M
+0.7% YoY
|
614.59M
612.16M – 617.02M
+4.1% YoY
|
655.15M
650.43M – 659.88M
+6.6% YoY
|
| EBIT |
386.30M
est: 396.14M (-2.5%)
|
524.80M
est: 528.67M (-0.7%)
|
656.25M
est: 556.23M (+18.0%)
|
259.76M
est: 495.30M (-47.6%)
|
498.72M
493.43M – 504.02M
+0.7% YoY
|
518.94M
516.89M – 520.99M
+4.1% YoY
|
553.18M
549.20M – 557.17M
+6.6% YoY
|
| Net Income |
300.92M
est: 295.23M (+1.9%)
|
416.30M
est: 457.06M (-8.9%)
|
522.45M
est: 504.29M (+3.6%)
|
198.00M
est: 213.21M (-7.1%)
|
219.07M
203.07M – 230.35M
+2.7% YoY
|
238.23M
217.88M – 261.46M
+8.7% YoY
|
280.00M
277.96M – 283.22M
+17.5% YoY
|
| SGA |
457.27M
est: 403.06M (+13.4%)
|
633.92M
est: 638.35M (-0.7%)
|
702.23M
est: 671.62M (+4.6%)
|
655.82M
est: 598.05M (+9.7%)
|
602.18M
595.79M – 608.58M
+0.7% YoY
|
626.59M
624.11M – 629.06M
+4.1% YoY
|
667.94M
663.13M – 672.76M
+6.6% YoY
|
| EPS |
1.00
est: 0.97 (+3.0%)
|
1.39
est: 1.52 (-8.4%)
|
1.73
est: 1.67 (+3.5%)
|
0.66
est: 0.71 (-6.6%)
|
0.73
0.67 – 0.76
+3.3% YoY
|
0.82
0.72 – 0.87
+11.6% YoY
|
0.93
0.92 – 0.94
+14.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Raweewat Maschamadol | Acting CEO & Director | 108.0K | male |
| Lapasrada Lertpanurot | Chief Executive Officer & Director | 108.0K | female |
| Phisut Numsa | Chief Financial Officer & Director | 60.0K | male |
| Patomporn Ngamkham | Company Secretary | — | female |
| Praphawarin Longngam | Deputy Chief Executive Officer | — | female |
| Puvanart Jangjamyarn | Vice Chief Administrative Officer | — | male |
| Suparoek Jeebkratoke | Internal Audit Officer | — | male |
| Wilawan Lekhasak | Chief Accountant | — | female |
| Nutchapol Yainagnan | Vice Chief Financial Officer | — | male |
| Parichart Boonchaleaw | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MASTER.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
